Receptor activator of nuclear factor kappaB ligand is expressed in resident and inflammatory cells in aseptic and septic prosthesis loosening.
about
RANK-ligand and osteoprotegerin as biomarkers in the differentiation between periprosthetic joint infection and aseptic prosthesis looseningPeriprosthetic bone density as outcome of therapeutic response.[Joint endoprosthesis pathology. Histopathological diagnostics and classification].Age of donor alters the effect of cyclic hydrostatic pressure on production by human macrophages and osteoblasts of sRANKL, OPG and RANK.Do tissues from THA revision of highly crosslinked UHMWPE liners contain wear debris and associated inflammation?Two-piece zirconia implants supporting all-ceramic crowns: a prospective clinical study.Contributions of human tissue analysis to understanding the mechanisms of loosening and osteolysis in total hip replacement.Cyclodextrin-erythromycin complexes as a drug delivery device for orthopedic application.Proposal for a histopathological consensus classification of the periprosthetic interface membrane.Aseptic loosening of total joint replacements: mechanisms underlying osteolysis and potential therapies.TRAP-positive osteoclast precursors mediate ROS/NO-dependent bactericidal activity via TLR4Blockade of JNK and NFAT pathways attenuates orthopedic particle-stimulated osteoclastogenesis of human osteoclast precursors and murine calvarial osteolysis.The central role of wear debris in periprosthetic osteolysis.Genetic susceptibility to hip arthroplasty failure--association with the RANK/OPG pathwayThe role of oxidative stress in aseptic loosening of total hip arthroplasties.Genetic susceptibility to aseptic loosening following total hip arthroplasty: a systematic review.Periprosthetic osteolysis after total hip replacement: molecular pathology and clinical management.Extracellular matrix degradation and tissue remodeling in periprosthetic loosening and osteolysis: focus on matrix metalloproteinases, their endogenous tissue inhibitors, and the proteasome.[Revised consensus classification. Histopathological classification of diseases associated with joint endoprostheses].CD3+ lymphocytosis in the peri-implant membrane of 222 loosened joint endoprostheses depends on the tribological pairing.Tocotrienols Regulate Bone Loss through Suppression on Osteoclast Differentiation and Activity: A Systematic Review.
P2860
Q33577344-123188D9-769D-4D05-A49C-812D4C622558Q33965664-0962141E-229E-4945-B75E-28FBC98CFE56Q34180878-6BD74585-5032-4C75-B1E2-2EA7349705DDQ34667359-EEBFB558-B96D-4D33-B5E2-BBC413B158F0Q35078832-7746077F-BBCC-47F0-886F-5EBF98D15F64Q35204463-708167B3-226D-4C7E-86D6-82EDCE881A24Q35317316-98A8E3C5-B282-46D5-BF5D-D0413E51202AQ35656883-34EB0645-29B8-4BA9-8582-106DDC1A6527Q35770039-F0688697-6360-424D-ADE1-A5AC8555D167Q35901087-74EF0A79-4F43-4ABD-9C58-CCD9822538CDQ36061655-5AAFFDF5-B4E2-4388-B8CB-03E75263C878Q36385024-C9B3DEB8-827F-4E49-8DF0-5B88B4B3434FQ36796472-751CC7DB-795D-4055-91E6-C6B633A08C73Q36867041-9FEC0D13-5DF1-4F28-89EA-F89B929613D3Q37662751-0CF7F3ED-E906-45CE-893A-E65887DD4093Q37886401-5A7B7AD6-05F3-4CC9-B447-3B9357A5A597Q38152730-F0E564A5-1938-4398-80A5-33396D56FAB8Q42755979-9FC8E07E-9F3D-418E-8DB3-89CCB2BA4DC9Q45164159-6604632E-76AF-4D85-B47F-E2115E2507DFQ47124488-28A8689F-833E-4417-9865-ADC59CAA262EQ50142964-DCA940C2-5BCB-4B3D-B58B-FC21C44E2867
P2860
Receptor activator of nuclear factor kappaB ligand is expressed in resident and inflammatory cells in aseptic and septic prosthesis loosening.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Receptor activator of nuclear ...... d septic prosthesis loosening.
@en
Receptor activator of nuclear ...... d septic prosthesis loosening.
@nl
type
label
Receptor activator of nuclear ...... d septic prosthesis loosening.
@en
Receptor activator of nuclear ...... d septic prosthesis loosening.
@nl
prefLabel
Receptor activator of nuclear ...... d septic prosthesis loosening.
@en
Receptor activator of nuclear ...... d septic prosthesis loosening.
@nl
P2093
P2860
P1476
Receptor activator of nuclear ...... d septic prosthesis loosening.
@en
P2093
Frommelt L
Morawietz L
P2860
P304
P356
10.1080/03009740310003929
P577
2003-01-01T00:00:00Z